When fibrinolytic potential was evaluated, we identified that patients with cancer presented an increase in several parameters associated with plasmin generation (Table 2), that are evidenced by higher MA (p < 0.0001), an increase in the area under the curve (p < 0.0001), and shorter lag time (p < 0.0001). The gene discussed is PLG; the disease is cancer.